Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.
about
Caspase-3-mediated cleavage of Akt: involvement of non-consensus sites and influence of phosphorylationBlockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAASEvolutionary families of peptidase inhibitorsAnalysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics.Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.Modulation of PC1/3 activity by self-interaction and substrate binding.Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.The extended granin family: structure, function, and biomedical implicationsThe Spn4 gene of Drosophila encodes a potent furin-directed secretory pathway serpin.Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.Congenital ureteropelvic junction obstruction: human disease and animal models.The proprotein convertase SKI-1/S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors.ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine.A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity
P2860
Q24307737-71FBD68A-5928-4403-9371-A86DF0BDA4FBQ24336425-DF786B16-6A82-4B96-B176-A6F3A146E883Q24530704-74553E29-8BCD-4C13-9853-FDEEA862DC07Q33965305-D60F73ED-C814-4150-A04D-BFB686E7383EQ34132292-74FDF3CF-D4D1-4032-8CD7-9EBD434EAE59Q34679073-7DAA714E-F5BE-47D1-9F49-A9899F1F56BAQ34679398-12881C5C-4BDF-40FE-8779-14AD0A637C91Q34696850-3C3CAEB9-8133-4A71-8A5B-F501509F6677Q34700397-289EE2E2-9F53-483C-8C02-CF457BE2B22EQ36435653-252BE2E2-A7E1-429E-BD72-9C905FEA2023Q36666413-B4618543-CAC3-4865-9FBE-4195D29DA7E3Q36986034-F3C7910E-2EFF-4B7E-90EB-E99C0AF581C1Q37053834-BD7B1534-7B15-4D00-B274-85B530F99AE7Q37777427-047BA08A-6E0E-49DD-ADCD-EF7E5F4AF4BDQ40264454-FCDE7CDB-1CBD-4379-9229-FECC52A9B949Q47255468-ADB527DD-E135-45AE-A8B3-2F3CF0B219F8Q57249387-C774DF49-15F9-40A8-A1CC-F872AE0BB000
P2860
Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@ast
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@en
type
label
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@ast
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@en
prefLabel
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@ast
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@en
P2093
P2860
P356
P1476
Inhibitory specificity and pot ...... oward proprotein convertase 1.
@en
P2093
Chrétien M
Fricker LD
P2860
P304
32720-32728
P356
10.1074/JBC.M104064200
P407
P577
2001-07-02T00:00:00Z